Kaléo, a global leader in drug-delivery device combinations and auto-injector innovation and the makers of the only epinephrine auto-injector with voice guidance, AUVI-Q ® (epinephrine injection), ...

BOSTON (Oct. 24, 2024) – Anaphylaxis can come on suddenly and without warning, and because its symptoms can be fatal, it is scary for those who encounter it. Two new studies being presented at this ...

New guidelines on the management of anaphylaxis from the European Academy of Allergy and Clinical Immunology (EAACI) underscore the need to use intramuscular epinephrine as first-line treatment. The ...

Please provide your email address to receive an email when new articles are posted on . 23.7% of respondents said they would first use antihistamines for anaphylaxis. The top barrier to epinephrine ...

Adolescents with anaphylaxis are at increased risk of fatal outcomes. Gaps in their knowledge of day-to-day and emergency management have been identified. There are also gaps in services available to ...

Two new practice parameters from the Joint Task Force for Practice Parameters (JTFPP) offer evidence-based recommendations for the diagnosis and management of anaphylaxis and atopic dermatitis (AD) in ...

Anaphylaxis is an acute, life-threatening systemic hypersensitivity reaction requiring immediate recognition and intervention. Prompt intramuscular administration of adrenaline remains the cornerstone ...

Misinformation and outdated protocols contribute to the suboptimal management of anaphylaxis by patients and healthcare professionals, based on data from two new studies presented at the American ...

Symptom onset and cardiac arrest in pediatric cases of fatal food anaphylaxis frequently start outside a health care facility ...

The main treatment for anaphylaxis is epinephrine, usually given by injection. If you don’t have access to epinephrine, call 911 or seek emergency care immediately. The most effective way to manage ...

A groundbreaking consensus report on anaphylaxis – the severe reaction some people experience from bee stings, peanut butter exposures, medications, and the like – has been released by the Global ...

By John Vandermosten, CFA NYSE:NSRX READ THE FULL NSRX INITIATION RESEARCH REPORT We are initiating coverage of Nasus Pharma Ltd. (NYSE:NSRX) with a valuation of $19.00 per share. This value is based ...